Literature DB >> 24100528

Care transitions programs: a review of hospital-based programs targeted to reduce readmissions.

Dennis R Delisle1.   

Abstract

PURPOSE/
OBJECTIVES: An emphasis on a value-based payment model is expected to provide motivation for developing effective care transitions programs. For such programs to succeed, organizations must adopt an evidence-based, financially feasible model that enables improved coordination with providers, alignment of incentives, and measurement of key performance metrics, both clinical and operational. Evidence of cost-effective care transitions programs is important for deploying successful models broadly. PRIMARY PRACTICE SETTING(S): Hospital-based programs. FINDINGS/
CONCLUSIONS: Current literature on care transitions programs highlights different strategies, patient populations, settings, and outcomes; however, it lacks sufficient supporting financial evidence that these programs are operationally sustainable and cost-effective within current and projected reimbursement schemes. IMPLICATIONS FOR CASE MANAGEMENT PRACTICE: Care transitions interventions need to be further studied in different settings with different patient populations to identify the optimal approach(es). An additional opportunity for future investigation lies in translation of interventional programs targeted at readmission diseases in line for penalty by Medicare.

Entities:  

Mesh:

Year:  2013        PMID: 24100528     DOI: 10.1097/NCM.0b013e31829d9cf3

Source DB:  PubMed          Journal:  Prof Case Manag        ISSN: 1932-8087


  2 in total

1.  Economic evaluation of the differential benefits of home visits with telephone calls and telephone calls only in transitional discharge support.

Authors:  Frances Kam Yuet Wong; Ching So; June Chau; Antony Kwan Pui Law; Stanley Ku Fu Tam; Sarah McGhee
Journal:  Age Ageing       Date:  2014-10-29       Impact factor: 10.668

2.  Stakeholder perceptions of a new model of care for medication supply at hospital discharge.

Authors:  Sally Wright; Charles W Morecroft; Rachel Mullen; Alison B Ewing
Journal:  Eur J Hosp Pharm       Date:  2018-04-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.